4.7 Article

Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage

Journal

NEUROBIOLOGY OF DISEASE
Volume 166, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2022.105662

Keywords

Neurofilament light; Cerebrospinal fluid; Alzheimer disease; Aging; White matter; Cerebrovascular disease

Categories

Funding

  1. Bright Focus [A2021012F]
  2. Alzheimer's Association [BAND-19-613876]
  3. National Institute of Health (NIH) [R01NR012907, R01NR012657, R01NR014449, R01AG052550, R01AG057680, P01AG00391, P01AG026276, P01AG005681, K01AG053474, U19AG032438, R03AG050921, K23AG053426]
  4. Barnes-Jewish Hospital
  5. Washington University Institute of Clinical and Translational Sciences Foundation [UL1 TR000448]
  6. Knight Alzheimer Disease Research Center
  7. Hope Center for Neurological Disorders
  8. Paula and Rodger O. Riney Fund
  9. Daniel J. Brennan MD Fund
  10. Fred Simmons and Olga Mohan Fund
  11. Avid Radiopharmaceuticals

Ask authors/readers for more resources

CSF NfL is a non-specific marker of aging and white matter integrity, and is more strongly associated with total white matter hyperintensity volume than with gray or white matter volume. Age and white matter hyperintensity volume are consistently more important predictors of CSF NfL than AD markers.
Background: Cerebrospinal fluid (CSF) neurofilament light chain (NfL) reflects neuro-axonal damage and is increasingly used to evaluate disease progression across neurological conditions including Alzheimer disease (AD). However, it is unknown how NfL relates to specific types of brain tissue. We sought to determine whether CSF NfL is more strongly associated with total gray matter, white matter, or white matter hyperintensity (WMH) volume, and to quantify the relative importance of brain tissue volume, age, and AD marker status (i.e., APOE genotype, brain amyloidosis, tauopathy, and cognitive status) in predicting CSF NfL.Methods: 419 participants (Clinical Dementia Rating [CDR] Scale > 0, N = 71) had CSF, magnetic resonance imaging (MRI), and neuropsychological data. A subset had amyloid positron emission tomography (PET) and tau PET. Pearson correlation analysis was used to determine the association between CSF NfL and age. Multiple regression was used to determine which brain volume (i.e., gray, white, or WMH volume) most strongly associated with CSF NfL. Stepwise regression and dominance analyses were used to determine the individual contributions and relative importance of brain volume, age, and AD marker status in predicting CSF NfL.Results: CSF NfL increased with age (r = 0.59, p < 0.001). Elevated CSF NfL was associated with greater total WMH volume (p < 0.001), but not gray or white matter volume (p's > 0.05) when considered simultaneously. Age and WMH volume were consistently more important (i.e., have greater R2 values) than AD markers when predicting CSF NfL.Conclusions: CSF NfL is a non-specific marker of aging and white matter integrity with limited sensitivity to specific markers of AD. CSF NfL likely reflects processes associated with cerebrovascular disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available